Introduction applied F(ab')2 fragments are formed as well (9). ,, - - . r · These anti-idiotypic antibodies interfere with the deFor the last couple of years the murme monoclonal . . , , . r If. .,, *-u r^r-4~>c · ·*·" 11 j i j u D * + /< homologous immuantibody OC125, initially developed by Bast et al. (1, termination of CA 125 when a ., .. . ., ^~4~c , , , -v «. . \ . . * 4.· r nometnc assay with OC125 antibodies as bothu the 2) to measure immunometncallynthe concentration of . _ .t. , , , . , ,, , .. , . , _ «ic · *i. r · *· * . immobilized and the labelled antibody is used. In an CA 125 in the serum of ovarian cancer patients, has ^i-i··, ···,· ·, ,. , . j. . ,. . j . . assay of this kind, anti-idiotypic antibodies can crossf also been used in vivo r radioimmunodetection of ,. , , , for ., !. , :, . ^ , , , . , /-A 125/-» A\ -n 4.1 4. * that · ' both ... antibodies,
Clinical Chemistry and Laboratory Medicine – de Gruyter
Published: Jan 1, 1993
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera